Schizophrenia: Evolution and Synthesis (Str

Silverstein, Steven M. [Editor]; Moghaddam, Bita [Editor]; Wykes, Til [Editor]; Silverstein, Steven M. [Contributor]; Moghaddam, Bita [Contributor]; Wykes, Til [Contributor]; MacDonald, Angus [Contributor]; Carpenter, William T. [Contributor]; Williams, Leanne M. [Contributor]; Corvin, Aiden [Contributor]; Buchanan, Robert W. [Contributor]; Kennedy, James L. [Contributor]; Keshavan, Matcheri S. [Contributor]; Sass, Louis [Contributor]; Wessa, Michèle [Contributor]; Jones, Peter B. [Contributor]; Cadenhead, Kristin S. [Contributor]; McGrath, John [Contributor]; Meyer-Lindenberg, Andreas [Contributor]; Morgan, Craig [Contributor]; O'Donovan, Michael [Contributor]; Bittner, Robert [Contributor]; Tost, Heike [Contributor]; Uhlhaas, Peter J. [C

ISBN 10: 0262019620 / ISBN 13: 9780262019620

Editore: Oxford University Press, USA, 2013

Riguardo questo articolo

Very Good Condition - May show some limited signs of wear and may have a remainder mark. Pages and dust cover are intact and not marred by notes or highlighting. Codice articolo MIT-HCD-NDJ-M-0262019620

Dati bibliografici

Titolo: Schizophrenia: Evolution and Synthesis (Str

Casa editrice: Oxford University Press, USA

Data di pubblicazione: 2013

Legatura: hardcover

Condizione: Very Good

Descrizione articolo

Riassunto:

Leading researchers address conceptual and technical issues in schizophrenia and suggest novel strategies for advancing research and treatment.

Despite major advances in methodology and thousands of published studies every year, treatment outcomes in schizophrenia have not improved over the last fifty years. Moreover, we still lack strategies for prevention and we do not yet understand how the interaction of genetic, developmental, and environmental factors contribute to the disorder. In this book, leading researchers consider conceptual and technical obstacles to progress in understanding schizophrenia and suggest novel strategies for advancing research and treatment.

The contributors address a wide range of critical issues: the construct of schizophrenia itself; etiology, risk, prediction, and prevention; different methods of modeling the disorder; and treatment development and delivery. They identify crucial gaps in our knowledge and offer creative but feasible suggestions. These strategies include viewing schizophrenia as a heterogeneous group of conditions; adopting specific new approaches to prediction and early intervention; developing better integration of data across genetics, imaging, perception, cognition, phenomenology, and other fields; and moving toward an evidence-based, personalized approach to treatment requiring rational clinical decision-making to reduce functional disability.

Contributors
Robert Bittner, Robert W. Buchanan, Kristin S. Cadenhead, William T. Carpenter, Jr., Aiden Corvin, Daniel Durstewitz, André A. Fenton, Camilo de la Fuente-Sandoval, Jay A. Gingrich, Joshua A. Gordon, Chloe Gott, Peter B. Jones, René S. Kahn, Richard Keefe, Wolfgang Kelsch, James L. Kennedy, Matcheri S. Keshavan, Angus W. MacDonald III, Anil K. Malhotra, John McGrath, Andreas Meyer-Lindenberg, Kevin J. Mitchell, Bita Moghaddam, Vera A. Morgan, Craig Morgan, Kim T. Mueser, Karoly Nikolich, Patricio O'Donnell, Michael O'Donovan, William A. Phillips, Wulf Rössler, Louis Sass, Akira Sawa, Jeremy K. Seamans, Steven M. Silverstein, William Spaulding, Sharmili Sritharan, Heike Tost, Peter Uhlhaas, Aristotle Voineskos, Michèle Wessa, Leanne M. Williams, Ashley Wilson, Til Wykes

L'autore:

Steven M. Silverstein is Director of the Division of Schizophrenia Research at University Behavioral HealthCare, Rutgers Biomedical and Health Services, Rutgers University.